nephrotic & nephritic Flashcards
nephrotic syndrome diseases
Minimal change disease, FOCAL SEGMENTAL GLOMERULOSCLEROSIS, Membranous GN
Nephritic Syndrome diseases
ACUTE DIFFUSE PROLIFERATIVE GN, RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS, IgA NEPHROPATHY, MEMBRANOPROLIFERATIVE GN
lipoid nephrosi
Minimal change disease
nil change disease
Minimal change disease
Minimal change disease etiology
Dysfunction of T-cells
Minimal change disease associated with
Podocytes Fusion (foot processes) of epithelial cells
Almost normal glomerulus by Light Microscope (LM)
Most common cause of Nephrotic Syndrome in children
Minimal change disease
Minimal change disease incidence in adults and children
10%, 65%
Minimal change disease age group
2-6 y 1w after uti or immunization
Minimal change disease distungsting feature
selective protinuria
Minimal change disease clinical course
selective proteinuria, normal renal function & respond to steroid
Minimal change disease labratory findingds
lm normal
if negative
em podocytes fusion
FOCAL SEGMENTAL GLOMERULOSCLEROSIS etiology
HIV, heroin addiction, obesity, SCd, glomerular scarring, maladaptation, inherited & primary disease
FOCAL SEGMENTAL GLOMERULOSCLEROSIS congenital forms:
mutations at APOL1 on ch.22 and increased risk of RF and FSGS, in africans
These mutations affect cytoskeletal or related proteins in podocytes (Nephrin)
FOCAL SEGMENTAL GLOMERULOSCLEROSIS lm
Collapse of BM
↑ mesangial matrix
Deposition of hyaline masses (hyalinosis)
FOCAL SEGMENTAL GLOMERULOSCLEROSIS em
Loss of podocytes.
Focal denudation of epithelial cells.
FOCAL SEGMENTAL GLOMERULOSCLEROSIS if
IgM & C3 deposition.
FOCAL SEGMENTAL GLOMERULOSCLEROSIS clinical
higher incidence of hematuria, ↓ GFR, & HT.
Nonselective proteinuria
poor response to steroids.
FOCAL SEGMENTAL GLOMERULOSCLEROSIS incidence
10% CHILDREN, 35% ADULTS
Membranous GN incidence
Adults 30%, children 5%
Membranous GN autoantibodies
M-type phospholipase A2 receptor–70% of the cases (important), Aldose reductase, Maganese superoxide dismutase 2,Membrane metalloendopeptidase.
Membranous GN most common autoantibodies
M-type phospholipase A2 receptor
Membranous GN prognosis
33% spontaneously remission.
33% stable with proteinuria.
33% progress to ESRD
Membranous GN LM
Thick capillary Wall without proliferation
Silver stain: spikes
wire loop lesion.
Membranous GN EM
Diffuse subepithelial deposits.
Membranous GN if
Granular IgG & C3 deposition.
Nephritic Syndrome manifestation
hematuria, htn, high blood urea, high serum creatinine, edema
Nephritic Syndrome pathogensis
Inflammatory lesions of glomeruli
Nephritic Syndrome clinical
Reduced GFR, htn, oliguria, fluid retention, and azotemia
ACUTE DIFFUSE PROLIFERATIVE GN etiology
1-4w after group a streptococcus b hemolytic infection
ACUTE DIFFUSE PROLIFERATIVE GN pathogensis
↑ ASO titer (Anti-streptolysin O)
Immune-complex disease/ Circulating or implanted Ag ↓ serum complement
Implicated Ags, SpeB, GAPDH, endostreptosin & plasmin binding protein
ACUTE DIFFUSE PROLIFERATIVE GN lm
Diffuse proliferation & leukocytic infiltration
ACUTE DIFFUSE PROLIFERATIVE GN em
subepithelial humps
ACUTE DIFFUSE PROLIFERATIVE IF
granular IgG & C3 in GBM and Mesangium